Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trialJan J. De Waele, Alain Verstraete, Sofie Carrette et al.|Intensive Care Medicine|2013Cited by 190
Colonization Status and Appropriate Antibiotic Therapy for Nosocomial Bacteremia Caused by Antibiotic-Resistant Gram-Negative Bacteria in an Intensive Care UnitStijn Blot, Koenraad Vandewoude, Pieter Depuydt et al.|Infection Control and Hospital Epidemiology|2005Cited by 104
Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational studyLiesbet De Bus, Pieter Depuydt, Wouter Denys et al.|Intensive Care Medicine|2016Cited by 81
A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registrationLiesbet De Bus, Pieter Depuydt, Bram Gadeyne et al.|Critical Care|2018Cited by 59
A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitalsFranky Buyle, Dirk Vogelaers, Johan Decruyenaere et al.|European Journal of Clinical Microbiology & Infectious Diseases|2012Cited by 38